Tiverton Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Tiverton Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$66K	Hold	7,316	–	–	﹤0.01%	677
2019 Q2	$79K	Buy	+7,316	New	+$77.8K	﹤0.01%	641
2019 Q1	–	Sell	-85,781	Closed	-$984K	–	662
2018 Q4	$984K	Sell	85,781 -25,770	-23%	-$320K	0.06%	180
2018 Q3	$1.89M	Buy	111,551 +94,487	+554%	+$1.44M	0.09%	143
2018 Q2	$242K	Buy	+17,064	New	+$283K	0.01%	297
2015 Q3	–	Sell	-556,800	Closed	-$6.17M	–	155
2015 Q2	$6.17M	Sell	556,800 -50,000	-8%	-$645K	0.12%	126
2015 Q1	$9.51M	Hold	606,800	–	–	0.19%	106
2014 Q4	$9.23M	Hold	606,800	–	–	0.19%	106
2014 Q3	$6.55M	Hold	606,800	–	–	0.15%	109
2014 Q2	$9.27M	Hold	606,800	–	–	0.21%	99
2014 Q1	$11M	Hold	606,800	–	–	0.24%	97
2013 Q4	$8.43M	Hold	606,800	–	–	0.19%	100
2013 Q3	$6.37M	Hold	606,800	–	–	0.15%	102
2013 Q2	$4.74M	Buy	+606,800	New	+$5.29M	0.12%	100

Other funds holding SGMO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tiverton Asset Management's SGMO Position: Q3 2019 in Review

Tiverton Asset Management held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2019 at 7,316 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #677.

Tiverton Asset Management first reported a position in SGMO in Q2 2013 and has held it in 14 quarters since. The position peaked at $11M in Q1 2014. 184 funds tracked by Wall St. Rank hold SGMO as of Q3 2019.

Tiverton Asset Management held 7,316 shares of SANGAMO THERAPEUTICS INC worth $66K as of Q3 2019.
Tiverton Asset Management left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2019.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #677 holding.
Tiverton Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 14 quarters since.
Tiverton Asset Management's SANGAMO THERAPEUTICS INC position peaked at $11M in Q1 2014.
184 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.